You are here

  • Home
  • Archive
  • Volume 58, Issue 10
  • Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort

Article metrics

Article menu
Download PDFPDF
Biochemical genetics
Original research
Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort

 

Online download statistics by month:

Online download statistics by month: September 2020 to May 2023

AbstractFullPdf
Sep 20206553724
Oct 20203682322
Nov 2020159123
Dec 2020186105
Jan 202113992
Feb 2021203157
Mar 202120294
Apr 2021211106
May 202157105
Jun 2021543
Jul 2021981
Aug 2021542
Sep 202114106
Oct 20213812115
Nov 2021434169
Dec 2021180615
Jan 2022222133
Feb 2022215510
Mar 202220537
Apr 202218652
May 202214964
Jun 202218062
Jul 202212951
Aug 20222071913
Sep 20222611213
Oct 20223821116
Nov 202238964
Dec 202214921
Jan 202319466
Feb 202324956
Mar 2023257145
Apr 2023164122
May 202320053
Total6946339227